Details for New Drug Application (NDA): 012429
✉ Email this page to a colleague
NDA 012429 describes THIOGUANINE, which is a drug marketed by Waylis Therap and is included in one NDA. It is available from three suppliers. Additional details are available on the THIOGUANINE profile page.
The generic ingredient in THIOGUANINE is thioguanine. Three suppliers are listed for this compound. Additional details are available on the thioguanine profile page.
The generic ingredient in THIOGUANINE is thioguanine. Three suppliers are listed for this compound. Additional details are available on the thioguanine profile page.
Summary for 012429
| Tradename: | THIOGUANINE |
| Applicant: | Waylis Therap |
| Ingredient: | thioguanine |
| Patents: | 0 |
Suppliers and Packaging for NDA: 012429
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| THIOGUANINE | thioguanine | TABLET;ORAL | 012429 | NDA | Woodward Pharma Services LLC | 69784-630 | 69784-630-25 | 1 BOTTLE in 1 CARTON (69784-630-25) / 25 TABLET in 1 BOTTLE |
| THIOGUANINE | thioguanine | TABLET;ORAL | 012429 | NDA | Aspen Global Inc. | 76388-880 | 76388-880-25 | 1 BOTTLE in 1 CARTON (76388-880-25) / 25 TABLET in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
